Fluoride for the treatment of postmenopausal osteoporotic fractures: A meta-analysis

Osteoporosis International

Volumn 11, Issue 9, 2000, Pages 727-738

  Haguenauer, D ^a   Welch, V ^a   Shea, B ^a   Tugwell, P ^b   Adachi, J D ^c   Wells, G ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c ST JOSEPH S HOSPITAL   (Canada)

Author keywords

Bone mineral density; Fluoride; Fracture; Meta analysis; Osteoporosis; Randomized controlled trials

Indexed keywords

CALCIUM; FLUORIDE SODIUM; FLUOROPHOSPHATE; VITAMIN D;

ADULT; AGED; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MINERAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; LUMBAR SPINE; META ANALYSIS; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLOW DRUG RELEASE; VERTEBRA FRACTURE;

AGED; BONE DENSITY; CALCIUM; CASE-CONTROL STUDIES; DELAYED-ACTION PREPARATIONS; DRUG THERAPY, COMBINATION; ESTROGEN REPLACEMENT THERAPY; FEMALE; FLUORIDES; FRACTURES, BONE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; RANDOMIZED CONTROLLED TRIALS; RISK; TREATMENT OUTCOME; VITAMIN D;

EID: 0033669403     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001980070051     Document Type: Article

References (73)

1. Consensus development conference: Diagnosis, prophylaxis and treatment of osteoporosis
2. Current and projected rates of hip fractures in Canada
3. An assessment of the burden of illness due to osteoporosis in Canada
4. The essential trace elements
5. Effect of sodium fluoride on calcium metabolism in human beings
6. The effect of sodium fluoride on trabecular architecture
7. Effect of sodium fluoride, calcium, phosphate, and vitamin D2 on trabecular bone balance and remodeling in osteoporotics
8. Osteoporosis: Review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis. Status report
9. Stress fractures of the lower limbs in osteoporotic patients treated with fluoride
10. Trabecular stress fractures during fluoride therapy for osteoporosis
11. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis
12. Fluoride in bone and serum druing treatment of osteoporosis with sodium fluoride, calcium and vitamin D
13. Developing optimal search strategies for detecting clinically sound studies in MEDLINE
14. Responsiveness of endpoints in osteoporosis clinical trials
15. Biochemical markers of bone turnover: Theoretical considerations and clinical use in osteoporosis
16. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
17. Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis: Comparison with conventional therapy
18. The statistical basis of meta-analysis
19. Prevention of early postmenopausal bone loss: Controlled 2-year study in 315 normal females
20. Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: The FAVOStudy
21. Treatment of postmenopausal vertebral osteopenia with monofluorophospate: A long-term calcium-controlled study
22. Relief of osteoporotic backache with fluoride, calcium, and calciferol
23. The effect of fluoride and calcium on spinal bone mineral content: A controlled, prospective (3 years) study
24. A randomized trial ofsodium fluoride as a treatment for postmenopausal osteoporosis
25. Slow-release sodium fluoride in the management of postmenopausal osteoporosis: A randomized controlled trial
26. Treatment of postmenopausal osteoporosis with slow-release sodium fluoride: Final report of a randomized controlled trial
27. The effect of sodium monofluorophosphate plus calcium on vertebral fracture rote in postmenopausal women with moderate osteoporosis: A randomized, controlled trial
28. Monofluorophosphate increases lumbar bone density in osteopenic patients: A double-masked randomized study
29. Evidence of fluoride-induced effects on the calcaneus by measurements of broadband ultrasound attenuation (BUA)
30. Fluoride therapy in postmenopausal osteopenic women: Effect on vertebral and femoral bone density and prediction of bone response
31. Histomorphometric analysis of iliac crest bone biopsies in placebo-treated versus fluoride-treated subjects
32. Extended treatment of primary osteoporosis by sodium fluoride combined with 25-hydroxycholecalciferol
33. Effect of combined therapy with sodium fluoride, vitamin D, and calcium in osteoporosis
34. Fluoride and osteoporosis
35. Prophylactic fluoride treatment and aged bones
36. Long-term fluoride therapy of postmenopausal osteoporosis
37. Fluoride therapy of osteoporosis
38. Sodium fluoride in the treatment of osteoporosis
39. Three-year changes in bone mineral mass of postmenopausal osteoporotic patients based on neutron activation analysis of the central third of the skeleton
40. Effect of slow-release sodium fluoride on cancellous bone histology and connectivity in osteoporosis
41. Studies on pathogenesis and treatment in postmenopausal and senile osteoporosis
42. Prophylactic fluoride treatment and aged bones
43. Effect of Combined therapy and sodium fluoride, vitamin D and calcium in osteoporosis
44. Measurement of intrinsic bone quality in vivo by reflection ultrasound: Correction of impaired quality with slow-release sodium fluoride and calcium citrate
45. Three years' experience with sodium-fluoride theraphy of osteoporosis
46. Evidence that fluoride therapy increases trabecular bone density in a peripheral skeletal site
47. Calcium deficiency in fluoride-treated osteoporotic patients despite calcium supplementation
48. A new fluoride preparation for the prevention of postmenopausal osteoporosis: Calcium monofluorophosphate
49. Serum fluoride and serum osteocalcin levels in response to a novel sustained-release monofluorophosphate preparation: Comparison with plain monofluorophosphate
50. Fluoride therapy and parathyroid hormone activity in osteoporosis
51. Comparison of serum fluoride levels after administration of monofluorophosphate-calcium carbonate or sodium fluoride: Differences in peak serum concentrations
52. 2 on trabecular bone balance and remodeling in osteoporotics
53. The effect of intermittent slow-release sodium fluoride and continuous calcium citrate therapy on calcitropic hormones, biochemical markers of bone metabolism, and blood chemistry in postmenopausal osteoporosis
54. Effect of fluoride n human osteoporotic bone mineral: A chemical and crystallographic study
55. Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis
56. Increased incidence of hip fracture in osteoporotic women treated with sodium fluoride
57. Combined fluoride therapy for primary osteoporosis. Results of two-years' treatment with sodium monofluorophosphate and calcium
58. Avoidance of vertebral fractures in men with idiopathic osteoporosis by a three year therapy with calcium and low-dose intermittent monoflurophosphate
59. Effect of sodium fluoride, inorganic phosphate, and oxymetholone therapies in osteoporosis: A six year progress report
60. Clinical trial of fluoride therapy in postmenopausal osteoporotic women: Extended observations and additional analysis
61. Comparison of treatments in senile osteoporosis: Follow up for 12 months (authors' transl)
62. First- and second-year effects of trials of calcium supplementation on the loss of bone density in postmenopausal women
63. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. World Congress on Osteoporosis, Chicago, 2000
64. Fluoride bioavailability from immediate-released fluoride with calcium carbonate compared with slow release sodium fluoride with calcium citrate
65. Effect of fluoride dosage on bone density, sonic velocity and logitudinal modules of rabbits femur
66. Responsiveness of endpoints in osteoporosis clinical trials: An update
67. Discrepancies in normative data between Lunar and Hologic DXA systems
68. X-ray microanalysis of fluoride distribution in microfractue calluses in cancellous iliac bone from osteoporotic patients treated with fluoride anc untreated
69. Treatment of vertebral osteoporosis with disodium monofluorophosphate: Comparison with sodium fluoride
70. Sodium fluoride induced gastric mucosal lesions: Comparison with sodium monofluorophosphate
71. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators